Esophageal Squamous Cell Carcinoma (ESCC) Clinical Trials in Guangzhou, Guangdong
3 recruitingGuangzhou, Guangdong, China
Showing 1–3 of 3 trials
Recruiting
Phase 2
Adebrelimab Combined With Neoadjuvant Chemotherapy in Borderline Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma (ESCC)
Sun Yat-sen University42 enrolled1 locationNCT07638436
Recruiting
Phase 2
Adebrelimab Combined With Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma (ESCC)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University37 enrolled1 locationNCT07595770
Recruiting
Phase 2
Hypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma (ESCC)
Sun Yat-sen University134 enrolled1 locationNCT06912074